Insiders · ALNY

Bryan Supran

EVP, CLO and Secretary at Alnylam Pharmaceuticals, Inc. (ALNY) since September 2025

Bryan Supran has filed 3 insider reports with the SEC since September 2025, as EVP and CLO and Secretary at Alnylam Pharmaceuticals, Inc. (ALNY). The latest filing, on March 5, 2026, reports grant or award at Alnylam Pharmaceuticals, Inc. (ALNY).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Bryan Supran is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Alnylam Pharmaceuticals, Inc. logo
ALNY
Alnylam Pharmaceuticals, Inc.
EVP, CLO and Secretarysince September 202514,565$147.82Mar 5, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Bryan Supran with

Other insiders at the same companies

Questions about Bryan Supran

What is Bryan Supran's role at Alnylam Pharmaceuticals, Inc.?
Bryan Supran reports to the SEC as EVP and CLO and Secretary at Alnylam Pharmaceuticals, Inc. (ALNY), according to the latest filing on March 5, 2026.
How many shares does Bryan Supran own?
After the latest filing that states it, Bryan Supran directly owned 14,565 shares of Alnylam Pharmaceuticals, Inc. (ALNY). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Bryan Supran bought or sold stock recently?
No open-market purchases or sales by Bryan Supran are on file. The filings report grant or award.
How do I get alerts when Bryan Supran files?
Follow Bryan Supran on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Bryan Supran (SEC CIK 0001511797). Totals count each trade once, skipping amendments whose original is on file, from Sep 22, 2025 on. View on SEC EDGAR · Get this as JSON